This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Incyte Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Liang: Innovator in Bicyclic Amine CDK12 Inhibitors
Introduction
Michael Liang is a prominent inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors that target specific biological pathways.
Latest Patents
Michael Liang holds a patent for "Bicyclic Amine CDK12 Inhibitors." This innovative work focuses on creating compounds that can effectively inhibit the CDK12 enzyme, which plays a crucial role in various cellular processes.
Career Highlights
Michael is currently employed at Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has allowed him to explore and develop groundbreaking therapies that address unmet medical needs.
Collaborations
Michael has collaborated with talented coworkers, including Xin Li and Evan Styduhar. Their combined expertise has contributed to the advancement of research and development in their field.
Conclusion
Michael Liang is a dedicated inventor whose work in bicyclic amine CDK12 inhibitors showcases his commitment to innovation in the pharmaceutical industry. His contributions are paving the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile